IL6 and cancer: Therefore, IL-6 blockade can work synergically with genotoxic agents to effectively suppress p53 WT cancer growth or can be used in combination with p53 restoration therapy to improve the effectiveness of genotoxic anticancer chemotherapies in p53-compromised cancers.